Related Experiment Video
Updated: Jul 10, 2026

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat
Hiushan Ng1, Stefan-M Pulst, Duong P Huynh
1Rose Moss Laboratory for Parkinson and Neurodegenerative Diseases, Burns and Allen Research Institute, and Division of Neurology, Cedars-Sinai Medical Center, USA.
Abstract:
Spinocerebellar ataxia 2 (SCA2) belongs to the group of neurodegenerative diseases caused by expansion of a polyglutamine (polyQ) domain. Overexpression of mutant ataxin-2 causes cell death and Golgi dispersion in cell culture as well as morphologic and functional changes in mouse models. To further define the mechanism of ataxin-2 induced cell death, we compared the cytotoxic effects of different domains of normal and mutant ataxin-2. N-terminal truncated ataxin-2(N) with expanded polyQ repeats did not form intranuclear inclusion and was less cytotoxic than the corresponding full-length ataxin-2. Ataxin-2(del42)[Q22], which lacks 42 amino acids (aa) within the Lsm-associated domain (LsmAD) necessary for Golgi localization, showed a diffuse cytoplasmic localization and was more toxic than wild type ataxin-2[Q22]. Mutant ataxin-2(del42)[Q108] displayed the same toxicity as ataxin-2[Q108], but did not disperse the Golgi apparatus to the extent seen with full-length mutant proteins. These observations confirm that ataxin-2 cytotoxicity increases with increasing polyQ expansion and Golgi dispersion and indicate that, in contrast to other polyQ diseases, N-terminal fragments containing the polyQ repeat are less toxic than full-length ataxin-2. Deletion of 42 aa in the Lsm-AD in ataxin-2 results in cytotoxicity without significant abnormalities in the Golgi apparatus. These findings suggest that the C-terminal domains are important for ataxin-2 cytotoxicity and that Golgi abnormalities may not be primary in the pathogenic process.
Insights
Spinocerebellar ataxia 2 (SCA2) involves mutant ataxin-2 protein fragments. Findings suggest C-terminal domains are key to SCA2 cytotoxicity, not Golgi abnormalities.
Area of Science:
- Neurobiology
- Molecular Biology
- Genetics
Background:
- Spinocerebellar ataxia 2 (SCA2) is a neurodegenerative disease linked to polyglutamine (polyQ) expansion.
- Mutant ataxin-2 overexpression causes cell death and Golgi dispersion, impacting cellular function.
Purpose of the Study:
- To investigate the mechanism of ataxin-2-induced cell death.
- To compare the cytotoxic effects of different domains of normal and mutant ataxin-2.
Main Methods:
- Comparison of cytotoxic effects of truncated vs. full-length ataxin-2 variants with varying polyQ lengths.
- Analysis of Golgi localization and dispersion in response to ataxin-2 mutations.
Main Results:
- N-terminal truncated ataxin-2 with expanded polyQ was less cytotoxic and did not form intranuclear inclusions.
- Ataxin-2 lacking Lsm-associated domain (LsmAD) showed increased toxicity and diffuse cytoplasmic localization.
- Mutant ataxin-2(del42)[Q108] was as toxic as full-length but caused less Golgi dispersion.
Conclusions:
- Ataxin-2 cytotoxicity correlates with polyQ expansion and Golgi dispersion.
- Unlike other polyQ diseases, N-terminal fragments are less toxic than full-length ataxin-2.
- Cytotoxicity can occur without significant Golgi abnormalities, suggesting C-terminal domains are crucial and Golgi issues may not be primary in SCA2 pathogenesis.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Botulism
Caspases
